First, the M+2+6− metric can be generated from diagnostic IHC scores, offering a refined method for utilizing MYC, BCL2, and BCL6 expression for prognostic use in DLBCL. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.